Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

467
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
467
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

798
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
798
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Survival Tree01:19

Survival Tree

325
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
325
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

744
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
744

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiseptic Cleansing to Reduce Vertical Transmission of Pathogens to Neonates: The NeoVT-AMR Randomized Clinical Trial.

JAMA network open·2026
Same author

CMV viraemia is associated with mortality among children with HIV starting antiretroviral therapy in sub-Saharan Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda.

The New England journal of medicine·2026
Same author

Multicenter Validation of Clinical Sepsis Phenotypes.

JAMA network open·2026
Same author

Impact of co-amoxiclav versus amoxicillin on the gastrointestinal microbiota in sub-Saharan children hospitalized with pneumonia.

npj antimicrobials and resistance·2026
Same author

How to design a ROCI (Response Over Continuous Intervention) randomised trial: guidance and a case study.

BMC medical research methodology·2026

Related Experiment Video

Updated: Dec 21, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.1K

Multi-Label Random Forest Model for Tuberculosis Drug Resistance Classification and Mutation Ranking.

Samaneh Kouchaki1, Yang Yang1,2, Alexander Lachapelle1

  • 1Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom.

Frontiers in Microbiology
|May 12, 2020
PubMed
Summary

Multi-label random forest models improve prediction of drug resistance in Tuberculosis by analyzing multiple drug resistance patterns simultaneously. This approach enhances accuracy and identifies key mutations for better treatment strategies.

Keywords:
MLRFSLRFdrug resistancemutation rankingtuberculosis

More Related Videos

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

355

Related Experiment Videos

Last Updated: Dec 21, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.1K
Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

355

Area of Science:

  • Genomics
  • Computational Biology
  • Infectious Disease Research

Background:

  • Drug resistance co-occurrence is common in *Mycobacterium tuberculosis* due to standard antibiotic regimens.
  • Analyzing multiple drug resistance patterns simultaneously can improve prediction accuracy.
  • Identifying key mutations aids in understanding and combating tuberculosis resistance.

Purpose of the Study:

  • To compare multi-label random forest (MLRF) models with single-label random forest (SLRF) for predicting phenotypic resistance.
  • To identify important mutations for predicting resistance to four first-line drugs in *Mycobacterium tuberculosis*.
  • To evaluate the effectiveness of MLRF in exploiting resistance co-occurrence patterns.

Main Methods:

  • Utilized whole genome sequences from 13402 *Mycobacterium tuberculosis* isolates.
  • Developed and compared MLRF and SLRF models for resistance prediction.
  • Identified and ranked important mutations associated with drug resistance and co-occurrence.

Main Results:

  • MLRF models demonstrated improved performance by 18.10% compared to conventional clinical methods and 0.91% over SLRFs.
  • A list of candidate mutations crucial for resistance prediction or related to co-occurrence was identified.
  • Retraining models with a subset of top-ranked mutations achieved satisfactory predictive performance.

Conclusions:

  • MLRF models offer a significant advancement in predicting drug resistance in *Mycobacterium tuberculosis*.
  • The study successfully identified key mutations and demonstrated the utility of resistance co-occurrence patterns.
  • This approach can lead to more effective and targeted tuberculosis treatment strategies.